Thermo Fisher Scientific announces collaboration with Symphogen to simplify therapeutic protein analysis
Thermo Fisher Scientific, the world leader in serving science, and Symphogen, a clinical-stage antibody oncology-focused company, have entered into a two-year collaborative partnership to deliver validated, platform workflows for simplified characterization and quality monitoring of complex therapeutic proteins. Building on a decade-long relationship, the